← Evidence map

ArticleOncotarget2017

Targeting CXCR4 reverts the suppressive activity of T-regulatory cells in renal cancer.

Sara Santagata et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

51 papers cite it

2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this paperpooled ittrialcites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 29100374